Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4064111
Max Phase: Preclinical
Molecular Formula: C30H46O4
Molecular Weight: 470.69
Molecule Type: Small molecule
Associated Items:
ID: ALA4064111
Max Phase: Preclinical
Molecular Formula: C30H46O4
Molecular Weight: 470.69
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC(=O)[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1
Standard InChI: InChI=1S/C30H46O4/c1-25(2)12-14-30(24(33)34)15-13-28(6)18(19(30)17-25)16-20(31)23-27(5)10-9-22(32)26(3,4)21(27)8-11-29(23,28)7/h16,19,21-23,32H,8-15,17H2,1-7H3,(H,33,34)/t19-,21-,22-,23+,27-,28+,29+,30-/m0/s1
Standard InChI Key: ILTQYWVUOPDTOL-DBWGAYEVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 470.69 | Molecular Weight (Monoisotopic): 470.3396 | AlogP: 6.41 | #Rotatable Bonds: 1 |
Polar Surface Area: 74.60 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 4.58 | CX Basic pKa: | CX LogP: 6.03 | CX LogD: 3.29 |
Aromatic Rings: 0 | Heavy Atoms: 34 | QED Weighted: 0.46 | Np Likeness Score: 3.23 |
1. Zhou M, Wang M, Zhong RF, Liao XM, Deng LL, Xu GB, He X, Li J, Li YJ, Liu T, Wang YL, Liao SG.. (2017) Discovery and structure-activity relationship of auriculatone: A potent hepatoprotective agent against acetaminophen-induced liver injury., 27 (16): [PMID:28729056] [10.1016/j.bmcl.2017.07.028] |
2. Minassi A, Rogati F, Cruz C, Prados ME, Galera N, Jinénez C, Appendino G, Bellido ML, Calzado MA, Caprioglio D, Muñoz E.. (2018) Triterpenoid Hydroxamates as HIF Prolyl Hydrolase Inhibitors., 81 (10): [PMID:30350996] [10.1021/acs.jnatprod.8b00514] |
3. Shen P, Zhang J, Zhu Y, Wang W, Yu B, Wang W.. (2020) Microbial transformation of glycyrrhetinic acid derivatives by Bacillus subtilis ATCC 6633 and Bacillus megaterium CGMCC 1.1741., 28 (11): [PMID:32299661] [10.1016/j.bmc.2020.115465] |
Source(1):